Patents by Inventor Ursula Germann

Ursula Germann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20030083467
    Abstract: The present invention relates to novel fusion proteins, DNA molecules encoding the same, vectors comprising the DNA molecules, and host cells containing the vectors for use in measuring protease activity using a novel transcriptional assay. This invention also relates to a method for determining the inhibitory activity of a compound against a protease and to a method for comparing the activity of two proteases which recognize the same cleavage site. Kits for assaying protease activity comprising DNA molecules encoding the fusion protein substrates of this invention are also contemplated.
    Type: Application
    Filed: November 20, 2002
    Publication date: May 1, 2003
    Inventors: Ursula Germann, Thomas Hoock, Ann Kwong
  • Patent number: 6528276
    Abstract: The present invention relates to novel fusion proteins, DNA molecules encoding the same, vectors comprising the DNA molecules, and host cells containing the vectors for use in measuring protease activity using a novel transcriptional assay. This invention also relates to a method for determining the inhibitory activity of a compound against a protease and to a method for comparing the activity of two proteases which recognize the same cleavage site. Kits for assaying protease activity comprising DNA molecules encoding the fusion protein substrates of this invention are also contemplated.
    Type: Grant
    Filed: May 12, 2000
    Date of Patent: March 4, 2003
    Assignee: Vertex Pharmaceuticals Inc.
    Inventors: Ursula Germann, Thomas Hoock, Ann Kwong
  • Patent number: 6117639
    Abstract: The present invention relates to novel fusion proteins, DNA molecules encoding the same, vectors comprising the DNA molecules, and host cells containing the vectors for use in measuring protease activity using a novel transcriptional assay. This invention also relates to a method for determining the inhibitory activity of a compound against a protease and to a method for comparing the activity of two proteases which recognize the same cleavage site. Kits for assaying protease activity comprising DNA molecules encoding the fusion protein substrates of this invention are also contemplated.
    Type: Grant
    Filed: August 31, 1998
    Date of Patent: September 12, 2000
    Assignee: Vertex Pharmaceuticals Incorporated
    Inventors: Ursula Germann, Thomas Hoock, Ann Kwong